Analysis of the Sensitivity to Endocrine Therapy (SET) assay in the PALLAS adjuvant trial of palbociclib in HR+/HER2- breast cancer (AFT-05).
- Citation:
- J Clin Oncol vol 24 (16_suppl) 538
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- AFT
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Pfizer
- Grants:
- AFT, ABCSG, Pfizer, ECOG-ACRIN, NSABP Foundation, GBG, BIG
- Corr. Author:
- Authors:
- Otto Metzger Karla Ballman Michael Gnant Mark Watson Eveline Chen Kevin Tran Patrick O'Brien Dominik Hlauschek Miguel Martin Justin M. Balko Zbigniew Nowecki Olwen Hahn Carsten Denkert C Curtis Yuan Liu Amylou C. Dueck Christian Fesl Erica Mayer Angela DeMichele William F. Symmans
- Networks:
- LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-TX035
- Study
- AFT-05
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: